Advertisement

CardioVascular and Interventional Radiology

, Volume 34, Issue 4, pp 691–704 | Cite as

Pediatric Vascular Malformations: Pathophysiology, Diagnosis, and the Role of Interventional Radiology

  • Anne Marie Cahill
  • Els Louisa Francine Nijs
Review

Abstract

The Mulliken and Glowacki classification (1982) differentiated vascular anomalies into two groups based on their endothelial characteristics: hemangiomas and vascular malformations. Vascular anomalies are localized defects of the vasculature that affect a limited number of vessels in a restricted area of the body. These defects are secondary to errors in vascular morphogenesis. Depending on the type of vessel involved, the vascular malformation group was subdivided into high-flow (such as arteriovenous malformation and arteriovenous fistula) and low-flow lesions (such as venous and lymphatic malformations). Depending on the type of lesion, the location and degree of involvement and the clinical effect, different types of treatment would be required. For the purpose of this review, we concentrate solely on vascular malformations: the clinical features, genetics, diagnosis, and current treatment options.

Keywords

Pediatric Paediatric interventions Embolization/embolisation Embolotherapy Sclerotherapy Vascular malformations 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422PubMedCrossRefGoogle Scholar
  2. 2.
    Puig S, Casati B, Staudenherz A, Paya K (2005) Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53:35–45PubMedCrossRefGoogle Scholar
  3. 3.
    North PE, Waner M, Buckmiller L, James CA, Mihm MC Jr (2006) Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 15:303–317PubMedCrossRefGoogle Scholar
  4. 4.
    Brouillard P, Vikkula M (2007) Genetic causes of vascular malformations. Hum Mol Genet 16(Spec No. 2):R140–R149PubMedCrossRefGoogle Scholar
  5. 5.
    Legiehn GM, Heran MK (2006) Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin N Am 37:435–474 (vii–viii)CrossRefGoogle Scholar
  6. 6.
    Dubois J, Alison M (2010) Vascular anomalies: what a radiologist needs to know. Pediatr Radiol 40:895–905PubMedCrossRefGoogle Scholar
  7. 7.
    Dubois J, Garel L (1999) Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 29:879–893PubMedCrossRefGoogle Scholar
  8. 8.
    Burrows PE, Laor T, Paltiel H, Robertson RL (1998) Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 16:455–488PubMedCrossRefGoogle Scholar
  9. 9.
    Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T (2005) Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 69:75–80PubMedCrossRefGoogle Scholar
  10. 10.
    Shiels WE II, Kenney BD, Caniano DA, Besner GE (2008) Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatric Surg 43:136–139 (discussion 140)CrossRefGoogle Scholar
  11. 11.
    Shiels WE II, Kang DR, Murakami JW, Hogan MJ, Wiet GJ (2009) Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg 141:219–224PubMedCrossRefGoogle Scholar
  12. 12.
    Okazaki T, Iwatani S, Yanai T et al (2007) Treatment of lymphangioma in children: our experience of 128 cases. J Pediatr Surg 42:386–389PubMedCrossRefGoogle Scholar
  13. 13.
    Dubois J, Garel L, Abela A, Laberge L, Yazbeck S (1997) Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 204:651–654PubMedGoogle Scholar
  14. 14.
    Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE (2006) Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 17:1639–1648PubMedCrossRefGoogle Scholar
  15. 15.
    Burrows PE, Mitri RK, Alomari A et al (2008) Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 6:209–216PubMedCrossRefGoogle Scholar
  16. 16.
    Poldervaart MT, Breugem CC, Speleman L, Pasmans S (2009) Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg 20:1159–1162PubMedCrossRefGoogle Scholar
  17. 17.
    Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF (2009) Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 67:251–256PubMedCrossRefGoogle Scholar
  18. 18.
    Ogita S, Tsuto T, Deguchi E, Tokiwa K, Nagashima M, Iwai N (1991) OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 26:263–268 (discussion 268–270)PubMedCrossRefGoogle Scholar
  19. 19.
    Blum RH, Carter SK, Agre K (1973) A clinical review of bleomycin–a new antineoplastic agent. Cancer 31:903–914PubMedCrossRefGoogle Scholar
  20. 20.
    Acevedo JL, Shah RK, Brietzke SE (2008) Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 138:418–424PubMedCrossRefGoogle Scholar
  21. 21.
    Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO (2004) Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 19:766–773PubMedCrossRefGoogle Scholar
  22. 22.
    Wiegand S, Eivazi B, Zimmermann AP et al (2009) Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment. Arch Otolaryngol Head Neck Surg 135:976–983PubMedCrossRefGoogle Scholar
  23. 23.
    Werner JA, Lippert BM, Gottschlich S et al (1998) Ultrasound-guided interstitial Nd:YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope 108:463–470PubMedCrossRefGoogle Scholar
  24. 24.
    Grimmer JF, Mulliken JB, Burrows PE, Rahbar R (2006) Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg 132:1251–1256PubMedCrossRefGoogle Scholar
  25. 25.
    Legiehn GM, Heran MK (2008) Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin North Am 46:545–597 (vi)PubMedCrossRefGoogle Scholar
  26. 26.
    Wouters V, Limaye N, Uebelhoer M et al (2010) Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 18:414–420PubMedCrossRefGoogle Scholar
  27. 27.
    Dompmartin A, Ballieux F, Thibon P et al (2009) Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol 145:1239–1244PubMedCrossRefGoogle Scholar
  28. 28.
    Trop I, Dubois J, Guibaud L et al (1999) Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 212:841–845PubMedGoogle Scholar
  29. 29.
    Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E (2001) Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 21:1519–1531PubMedGoogle Scholar
  30. 30.
    Moukaddam H, Pollak J, Haims AH (2009) MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 38:535–547PubMedCrossRefGoogle Scholar
  31. 31.
    van Rijswijk CS, van der Linden E, van der Woude HJ, van Baalen JM, Bloem JL (2002) Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol 178:1181–1187PubMedGoogle Scholar
  32. 32.
    Fayad LM, Hazirolan T, Carrino JA, Bluemke DA, Mitchell S (2008) Venous malformations: MR imaging features that predict skin burns after percutaneous alcohol embolization procedures. Skeletal Radiol 37:895–901PubMedCrossRefGoogle Scholar
  33. 33.
    Dubois JM, Sebag GH, De Prost Y, Teillac D, Chretien B, Brunelle FO (1991) Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. Radiology 180:195–198PubMedGoogle Scholar
  34. 34.
    Puig S, Aref H, Chigot V, Bonin B, Brunelle F (2003) Classification of venous malformations in children and implications for sclerotherapy. Pediatric Radiol 33:99–103Google Scholar
  35. 35.
    Lee BB (2005) New approaches to the treatment of congenital vascular malformations (CVMs)–a single centre experience. Eur J Vasc Endovasc Surg 30:184–197PubMedCrossRefGoogle Scholar
  36. 36.
    O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B (1997) Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 169:723–729PubMedGoogle Scholar
  37. 37.
    Chen Y, Li Y, Zhu Q et al (2008) Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol 190:966–971PubMedCrossRefGoogle Scholar
  38. 38.
    Wallace MJ, Kuo MD, Glaiberman C, Binkert CA, Orth RC, Soulez G (2008) Three-dimensional C-arm cone-beam CT: applications in the interventional suite. J Vasc Interv Radiol 19:799–813PubMedCrossRefGoogle Scholar
  39. 39.
    Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15:431–445PubMedCrossRefGoogle Scholar
  40. 40.
    Khandpur S, Sharma VK (2010) Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. Dermatol Surg 36:340–346PubMedCrossRefGoogle Scholar
  41. 41.
    Mendonca DA, McCafferty I, Nishikawa H, Lester R (2010) Venous malformations of the limbs: the Birmingham experience, comparisons and classification in children. J Plast Reconstr Aesthet Surg 63:383–389PubMedCrossRefGoogle Scholar
  42. 42.
    Yun WS, Kim YW, Lee KB et al (2009) Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg 50:581–589PubMedCrossRefGoogle Scholar
  43. 43.
    Mason KP, Michna E, Zurakowski D, Koka BV, Burrows PE (2000) Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology 217:127–132PubMedGoogle Scholar
  44. 44.
    Mason KP, Neufeld EJ, Karian VE, Zurakowski D, Koka BV, Burrows PE (2001) Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol 177:1359–1363PubMedGoogle Scholar
  45. 45.
    Uehara S, Osuga K, Yoneda A, Oue T, Yamanaka H, Fukuzawa M (2009) Intralesional sclerotherapy for subcutaneous venous malformations in children. Pediatr Surg Int 25:709–713PubMedCrossRefGoogle Scholar
  46. 46.
    Sidhu MK, Perkins JA, Shaw DW, Bittles MA, Andrews RT (2005) Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol 16:879–884PubMedGoogle Scholar
  47. 47.
    Min RJ, Khilnani N, Zimmet SE (2003) Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol 14:991–996PubMedGoogle Scholar
  48. 48.
    Proebstle TM, Gul D, Kargl A, Knop J (2003) Endovenous laser treatment of the lesser saphenous vein with a 940-nm diode laser: early results. Dermatol Surg 29:357–361PubMedCrossRefGoogle Scholar
  49. 49.
    Gloviczki P, Driscoll DJ (2007) Klippel-Trenaunay syndrome: current management. Phlebology 22:291–298PubMedCrossRefGoogle Scholar
  50. 50.
    Chaudry G, Padua HM, Alomari AI (2008) The use of inferior vena cava filters in young children. J Vasc Interv Radiol 19:1103–1106PubMedCrossRefGoogle Scholar
  51. 51.
    Raffini L, Cahill AM, Hellinger J, Manno C (2008) A prospective observational study of IVC filters in pediatric patients. Pediatr Blood Cancer 51:517–520PubMedCrossRefGoogle Scholar
  52. 52.
    Eerola I, Boon LM, Mulliken JB et al (2003) Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73:1240–1249PubMedCrossRefGoogle Scholar
  53. 53.
    Srinivasa RN, Burrows PE (2006) Dural arteriovenous malformation in a child with Bannayan-Riley-Ruvalcaba Syndrome. AJNR Am J Neuroradiol 27:1927–1929PubMedGoogle Scholar
  54. 54.
    Naidich JJ, Rofsky NM, Rosen R, Karp N (2001) Arteriovenous malformation in a patient with Bannayan–Zonana syndrome. Clin Imaging 25:130–132PubMedCrossRefGoogle Scholar
  55. 55.
    Tan WH, Baris HN, Burrows PE et al (2007) The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 44:594–602PubMedCrossRefGoogle Scholar
  56. 56.
    Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93:682–689PubMedCrossRefGoogle Scholar
  57. 57.
    Taschner CA, Gieseke J, Le Thuc V et al (2008) Intracranial arteriovenous malformation: time-resolved contrast-enhanced MR angiography with combination of parallel imaging, keyhole acquisition, and k-space sampling techniques at 1.5 T. Radiology 246:871–879PubMedCrossRefGoogle Scholar
  58. 58.
    Cho SK, Do YS, Shin SW et al (2006) Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther 13:527–538PubMedCrossRefGoogle Scholar
  59. 59.
    Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS (2004) Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 39:590–600PubMedCrossRefGoogle Scholar
  60. 60.
    Dickey KW, Pollak JS, Meier GH III, Denny DF, White RI Jr (1995) Management of large high-flow arteriovenous malformations of the shoulder and upper extremity with transcatheter embolotherapy. J Vasc Interv Radiol 6:765–773PubMedCrossRefGoogle Scholar
  61. 61.
    Jackson JE, Mansfield AO, Allison DJ (1996) Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol 19:323–328PubMedCrossRefGoogle Scholar
  62. 62.
    Shin BS, Do YS, Lee BB et al (2005) Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 235:1072–1077PubMedCrossRefGoogle Scholar
  63. 63.
    Do YS, Park KB, Park HS et al (2010) Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol 21:807–816PubMedCrossRefGoogle Scholar
  64. 64.
    Yakes WF, Rossi P, Odink H (1996) How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 19:65–71PubMedCrossRefGoogle Scholar
  65. 65.
    Mitchell SE, Shah AM, Schwengel D (2006) Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted? J Vasc Interv Radiol 17:253–262PubMedCrossRefGoogle Scholar
  66. 66.
    Starke RM, Komotar RJ, Otten ML et al (2009) Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 40:2783–2790PubMedCrossRefGoogle Scholar
  67. 67.
    Hamada J, Kai Y, Morioka M et al (2002) A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J Neurosurg 97:889–895PubMedCrossRefGoogle Scholar
  68. 68.
    Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I (2009) Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:99–106CrossRefGoogle Scholar
  69. 69.
    Rennert J, Herold T, Schreyer AG et al (2009) Evaluation of a liquid embolization agent (Onyx) for transcatheter embolization for renal vascular lesions. Rofo 181:996–1001PubMedGoogle Scholar
  70. 70.
    Pollak JS, White RI Jr (2001) The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 12:907–913PubMedCrossRefGoogle Scholar
  71. 71.
    Kacker A, Heier L, Jones J et al (2000) Large intraosseous arteriovenous malformation of the maxilla: a case report with review of literature. Int J Pediatr Otorhinolaryngol 52:89–92PubMedCrossRefGoogle Scholar
  72. 72.
    Corsten L, Bashir Q, Thornton J, Aletich V (2001) Treatment of a giant mandibular arteriovenous malformation with percutaneous embolization using histoacrylic glue: a case report. J Oral Maxillofac Surg 59:828–832PubMedCrossRefGoogle Scholar
  73. 73.
    Toker ME, Eren E, Akbayrak H et al (2006) Combined approach to a peripheral congenital arteriovenous malformation: surgery and embolization. Heart Vessels 21:127–130PubMedCrossRefGoogle Scholar
  74. 74.
    Rao VR, Mandalam KR, Gupta AK, Kumar S, Joseph S (1989) Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up. AJNR Am J Neuroradiol 10:135–141PubMedGoogle Scholar
  75. 75.
    De Luca D, Piastra M, Pietrini D, Rollo M, Conti G (2008) “Glue lung”: pulmonary micro-embolism caused by the glue used during interventional radiology. Arch Dis Child 93:263PubMedCrossRefGoogle Scholar
  76. 76.
    Smith SJ, Thomas A, Ashpole RD (2009) Intra-operative combustion of Onyx embolic material. Br J Neurosurg 23:76–78PubMedCrossRefGoogle Scholar
  77. 77.
    Jankowitz BT, Vora N, Jovin T, Horowitz M (2008) Treatment of pediatric intracranial vascular malformations using Onyx-18. J Neurosurg Pediatr 2:171–176PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

Authors and Affiliations

  • Anne Marie Cahill
    • 1
  • Els Louisa Francine Nijs
    • 1
  1. 1.Department of Interventional RadiologyChildren’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations